Long-term use of opioids and neuropathic medication after diaphyseal humerus fractures with or without nerve injury: a nationwide register-based cohort study of 4,185 patients.
6 affiliations
- 1Department of Orthopedic and Hand Surgery, Faculty of Medicine and Health, Örebro University, Örebro; Clinical Department of Hand Surgery, Plastic Surgery and Burns, Region Östergötland, Linköping University Hospital, Linköping; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. [email protected].
- 2Department of Orthopedics, Kalmar Hospital, Kalmar, Sweden.
- 3Department of Translational Medicine - Hand Surgery, Lund University, Skåne University Hospital, Malmö; Unit for Social Epidemiology, Department of Clinical Sciences (Malmö), Faculty of Medicine, Lund University, Malmö, Sweden.
- 4Department of Translational Medicine - Hand Surgery, Lund University, Skåne University Hospital, Malmö; Department of Orthopedics, Helsingborg Hospital, Helsingborg, Sweden.
- 5Unit for Social Epidemiology, Department of Clinical Sciences (Malmö), Faculty of Medicine, Lund University, Malmö; Center for Primary Health Research, Region Skåne, Malmö, Sweden.
- 6Department of Biomedical and Clinical Sciences, Linköping University, Linköping; Department of Translational Medicine - Hand Surgery, Lund University, Skåne University Hospital, Malmö, Sweden.
Abstract
Background and purpose
Diaphyseal humerus fractures may lead to prolonged pain medication use. We aimed to study pain medication use after such fractures, focusing on nerve injury.Methods
Using Swedish register data (2007-2015), we identified individuals with diaphyseal humerus fractures. High use of opioids and neuropathic pain medication (≥ 60% of days covered/year; 2-month post-fracture washout) was evaluated in 5 groups: the general population (reference) and fractures treated nonoperatively or surgically, with and without nerve injury. Relative risks (RRs; 95% confidence intervals [CIs]; crude and adjusted [aRR] models; adjusted for age, sex, country of birth, income, and cohabitation status; and for previous high use of pain medication during the first year when analyzing the second year) were estimated in Cox proportional hazards regression models.Results
We identified 4,185 individuals with diaphyseal humerus fractures (3.7% with nerve injury; 23% surgically treated). In the first year, opioid use was higher among surgically treated fractures with nerve injury (aRR 17.6, CI 11.0-28.3) and without nerve injury (aRR 9.5, CI 8.2-10.9) than in the general population. In the second year, opioid use declined across most groups but remained elevated among nonoperatively treated fractures with nerve injury (aRR 8.3, CI 2.6-26.1). Neuropathic pain medication use increased in the first year, with no elevated use in the second. Adjustment did not change overall patterns. Women, older adults, lower-income individuals, and those living alone showed higher medication risk use.Conclusion
Patients with a diaphyseal humerus fracture were associated with a substantial burden of pain medication use, particularly for opioids during the first year post-injury in surgically treated fractures with nerve injury (RR 17.6) and a persistent risk in the second year among nonoperatively treated fractures with nerve injury (RR 8.3). Demographics and socioeconomic factors strongly relate to medication use, highlighting the need for careful early pain management and monitoring for prolonged medication use in exposed groups.
Related
- A comparative study of Kirschner wire intramedullary fixation versus bicortical fixation for metaphyseal-diaphyseal junction fractures of the pediatric distal radius.
- Prognosis of 1st time revision due to pain following primary total hip arthroplasty - a nationwide cohort study from the Danish Hip Arthroplasty Register
- Postoperative Risks in Thoracolumbar Fractures Patients with Mental Disorders: A Retrospective Cohort Study Using a Nationwide Inpatient Database
- Academic achievements among siblings of children with cancer in Sweden: a nationwide register-based cohort study
- Prevalence and mortality of chronic extracellular matrix dysregulated diseases: a nationwide register-based study
BibTeX
@article{nyman2026longterm,
title = {{Long-term use of opioids and neuropathic medication after diaphyseal humerus fractures with or without nerve injury: a nationwide register-based cohort study of 4,185 patients.}},
author = {Erika Nyman and Simone Andersson and Raquel Perez and Malin Zimmerman and Juan Merlo and Lars B Dahlin},
journal = {Acta orthopaedica},
year = {2026},
month = oct,
doi = {10.2340/17453674.2026.46808},
url = {https://europepmc.org/article/MED/42961444},
note = {CC BY},
}
RIS
TY - JOUR
TI - Long-term use of opioids and neuropathic medication after diaphyseal humerus fractures with or without nerve injury: a nationwide register-based cohort study of 4,185 patients.
AU - Erika Nyman
AU - Simone Andersson
AU - Raquel Perez
AU - Malin Zimmerman
AU - Juan Merlo
AU - Lars B Dahlin
PY - 2026
DA - 2026/10/30
JO - Acta orthopaedica
DO - 10.2340/17453674.2026.46808
UR - https://europepmc.org/article/MED/42961444
AB - Background and purpose Diaphyseal humerus fractures may lead to prolonged pain medication use. We aimed to study pain medication use after such fractures, focusing on nerve injury.Methods Using Swedish register data (2007-2015), we identified individuals with diaphyseal humerus fractures. High use of opioids and neuropathic pain medication (≥ 60% of days covered/year; 2-month post-fracture washout) was evaluated in 5 groups: the general population (reference) and fractures treated nonoperatively or surgically, with and without nerve injury. Relative risks (RRs; 95% confidence intervals [CIs]; crude and adjusted [aRR] models; adjusted for age, sex, country of birth, income, and cohabitation status; and for previous high use of pain medication during the first year when analyzing the second year) were estimated in Cox proportional hazards regression models.Results We identified 4,185 individuals with diaphyseal humerus fractures (3.7% with nerve injury; 23% surgically treated). In the first year, opioid use was higher among surgically treated fractures with nerve injury (aRR 17.6, CI 11.0-28.3) and without nerve injury (aRR 9.5, CI 8.2-10.9) than in the general population. In the second year, opioid use declined across most groups but remained elevated among nonoperatively treated fractures with nerve injury (aRR 8.3, CI 2.6-26.1). Neuropathic pain medication use increased in the first year, with no elevated use in the second. Adjustment did not change overall patterns. Women, older adults, lower-income individuals, and those living alone showed higher medication risk use.Conclusion Patients with a diaphyseal humerus fracture were associated with a substantial burden of pain medication use, particularly for opioids during the first year post-injury in surgically treated fractures with nerve injury (RR 17.6) and a persistent risk in the second year among nonoperatively treated fractures with nerve injury (RR 8.3). Demographics and socioeconomic factors strongly relate to medication use, highlighting the need for careful early pain management and monitoring for prolonged medication use in exposed groups.
SN - 1745-3674
SN - 1745-3682
ER -